Full Length Research Paper
References
|
Aygun C (2015). Impact of metabolic syndrome on fibrosis progression in chronic hepatitis B infection. Journal of Metabolic Syndrome 4(2):175-178. |
|
|
Boyd A, Bottero J, Miailhes P, Lascoux-Combe C, Rougier H, Girard P, Serfaty L, Lacombe K. (2017). Liver fibrosis regression and progression during controlled hepatitis B virus infection among HIV–HBV patients treated with tenofovir disoproxil fumarate in France: a prospective cohort study. AIDS 20(1):112-121. |
|
|
Brian Z, Ma X (2012). Liver fibrogenesis in non-alcoholic steatohepatitis. Frontiers in Physiology 3:248-256. |
|
|
Castera L. (2011). Non-invasive assessment of liver fibrosis in chronic hepatitis C. Hepatology International 5(2):625-634. |
|
|
Chackrewarthy S, Gunasekera D, Pathmeswaren A, Wijekoon CN, Ranawaka UK, Kato N, Takeuchi F, Wickremasinhe,AR (2013). Clinical Study, A comparison between revised NCEP ATP III and IDF definitions of diagnosing metabolic syndrome in an Urban Sri Lankan population: The Ragama Health Study. ISRN Endocrinology 1:1-7. |
|
|
Cheng JY, Wong VW, Tse YK, Chim AM, Chan HL, Wong GL (2016). Metabolic syndrome increases cardiovascular events but not hepatic events and death in patients with chronic hepatitis B. Hepatology 64(5):1507-1517. |
|
|
Deng S, Xingshun Q, Xiaozhong G (2015). Diagnostic accuracy of APRI, AAR, FIB-4, FI, King Lok, Forns and Fibro Index scores in predicting the presence of esophagealvarices in liver cirrhosis, A systematic review and meta-analysis. Medicine 94(4):1795-1803. |
|
|
Dragut MR, Rusu E, Enache G, Poposcu H, Nan R, Radulian G (2016). Liver and metabolic diseases. Romanian Journal of Diabetes Nutrition and Metabolic Diseases 23(1):105-112. |
|
|
El-Serag, HB, Rudolf KL (2007). Hepatocellular carcinoma: epidemiology and molecular carcinoma carcinogenesis. Gastroenterology 132:2557-2576. |
|
|
Changotra, H, Dwivedi A, Nayyar, A.K. and Sehajpal, P.K. (2008). Diagnosing different stages of hepatitis B infection using a competitive polymerase chain reaction assay. Indian Journal of Medical Microbiology 26(2):138-142. |
|
|
Gristina V, Curpi MG, Torcho M, Mezzogori G, Cacciabue L (2015). Diabetes and Cancer: a critical appraisal of the pathogenesis and therapeutic links. Biomedical Reports 3:131-136. |
|
|
Hoebel S (2010). The association between anthropometric parameters, metabolic syndrome and microalbuminuria in black Africans in the SABPA study. Cardiovascular Journal of Africa 21(3):148-152. |
|
|
Howell S, Ladep NG, Lemoine M (2015). Prevention of liver fibrosis and cancer in Africa: the PROFILICA project- a corroborative study of hepatitis B-related liver disease in West Africa. South African Medical Journal105(3):78-85. |
|
|
Hsiang J, Wong GH, Chan HY, Wong VS (2014). Metabolic syndrome delays HBeAg seroclearance in Chinese patients with hepatitis B. Aliment. Pharmacology and Therapeutic 40(6):716-726. |
|
|
Jarcuska P, Drazilova S, Fedacko J, Pella D, Janicko M. (2016). Association between hepatitis B and metabolic syndrome: Current state of the art. World Journal of Gastroenterology 22(1):155-64. |
|
|
Kasmari JA, Welch A, Liu G, Leslie D, MacGarrity T, Reilly T (2017). Independent of cirrhosis, hepatoceelular carcinoma risk is increased with diabetes and metabolic syndrome. American Journal of Medicine 130(6):746e1-746e6. |
|
|
Katoonizadeh A, Ghoroghi S, Sharafkhah M, Khoshnia M, Mirzaei S, Shayanrad A, Poustchi H, Malekzadeh R (2016). Chronic hepatitis B infection is not associated with increased risk of vascular mortality while having an association with metabolic syndrome. Journal of Medical Virology 88(7):1230-1237. |
|
|
Kaur J (2014). A comprehensive review of metabolic syndrome. Cardiology Research and Practice 1:1-21. |
|
|
Krejcie VR, Morgan DW (1970). Determining sample size for research activities. Educational and Psychological Measurement 30:607-610. |
|
|
Kuo YH, Tsai MC, Kee KM, Chang KC, Wang JH, Lin CY, Lin SC, Lu SN (2016). Associated Factors for Metabolic Syndrome in the Older Adults with Chronic Virus Hepatitis in the Community. PLoS One 11(5):e0155544. |
|
|
Lee J, Yoo HS, Sohn W, Kim WH, Choi SY, Won JH, Heo JY, Park SJ, Park MY (2016). Obesity and hepatocellular carcinoma in patients reeiving entecavir for chronic hepatitis B. Clinical and Molecular Hepatology 22(3):339-349 |
|
|
Li Y, Zhao Y (2017). Serum HBV surface antigen positivity is associated with low prevalence of metabolic syndrome: A meta-analysis. PLoS One 56(4):45-51 |
|
|
Liaw YF, Chang ML (2014). Hepatitis B flares in chronic hepatitis B: pathogenesis, natural causes and management. Journal of Hepatology 61(6):1407-1417. |
|
|
Maud L, Karine L, Jan PB, Manuella S, Laurent F, Nadia V, Fellahi S cAapaeu J, Peirre-Marie G, Jean-luc M (2017). Metabolic syndrome and obesity are the cornerstones of liver fibrosis in HIV-monoinfected patients. AIDS 31(140):1955-1964. |
|
|
Mazzanti R, Arena U, Tassi R (2016). Hepatocellular carcinoma: Where are we? World Journal of Experimental Medicine 6(1):21-36. |
|
|
Nau AL, Soarces JC, Shiozawa MBC, Dantes-Correa EB, Schiavon LL Narciso-Sschiavon L (2014). Clinical and laboratory characteristics associated with dyslipidemia and liver steatosis in chronic hepatitis B carriers. Revista da Sociedade Brasileira de Medicina Tropical 42(2):158-164. |
|
|
Papastergiou V, Tsochatzis E, Burroughs A (2102). Non-invasive assessment of liver fibrosis. Annals of Gastroenterology 25(3):218-231. |
|
|
Pathik P, Ryan JD, Tsochatzis EA (2017). Fibrosis assessment in patients with chronic hepatitis B virus infection. Annals of Translational Medicine 5(3):40. |
|
|
Pedroza-Tobias A, Trejo-Valdivia B, Sanchez-Romero LM, Barquera S. (2014). Classification of metabolic syndrome according to lipid alterations: analysis from the Mexican National and Nutrition Survey, 2006. BMC Public Health 14:1056-1058 |
|
|
Rahman R, Hammond G, Ghassan MM, Ashraf AA, Almashhrawi AA, Ahmed KT, Ibdah JA (2013). Primary hepatocellular carcinoma and metabolic syndrome: an update. Journal of Gastrointestinal Oncology 5(9):186-194. |
|
|
Sugihara T, Kod M, Matono T, Okamato, K, Murawaki Y, Isomotoh H, Tokunaya S (2016). Risk assessment of heptatocellular carcinoma in general population by liver stiffness in combination with controlled attenuation parameter using transient elastography: a cross-sectional study. Yonago Acta Medica 60:106-112. |
|
|
Svegliati-Baroni G, Ridolfi, Hannivoort R., Saccomanoo S, Hoan M, Moshage H (2014). Bile acids induced hepatic stellate cells proliferation via activation of the epidermal growth factor. Gastroenterology 128:1042-1055. |
|
|
Van Der Meer A, Valal B, Feld J (2012). Association sustained virological response and all-cause mortality among patients with chronic hepatitis C and advanced hepatic fibrosis. Journal of the American Medical Association 308(24):2584-2593. |
|
Copyright © 2024 Author(s) retain the copyright of this article.
This article is published under the terms of the Creative Commons Attribution License 4.0
